...
首页> 外文期刊>Journal of enzyme inhibition and medicinal chemistry. >Recent developments on triazole nucleus in anticonvulsant compounds: a review
【24h】

Recent developments on triazole nucleus in anticonvulsant compounds: a review

机译:抗惊厥化合物中三唑核的最新研究进展

获取原文
           

摘要

Abstract Epilepsy is one of the common diseases seriously threatening life and health of human. More than 50 million people are suffering from this condition and anticonvulsant agents are the main treatment. However, side effects and intolerance, and a lack of efficacy limit the application of the current anticonvulsant agents. The search for new anticonvulsant agents with higher efficacy and lower toxicity continues to be the focus and task in medicinal chemistry. Numbers of triazole derivatives as clinical drugs or candidates have been frequently employed for the treatment of various types of diseases, which have proved the importance of this heterocyclic nucleus in drug design and discovery. Recently many endeavours were made to involve the triazole into the anticonvulsants design, which have brought lots of active compounds. This work is an attempt to systematically review the research of triazole derivatives in the design and development of anticonvulsant agents during the past two decades.
机译:摘要癫痫病是严重威胁人类生命和健康的常见疾病之一。超过5000万人患有这种疾病,抗惊厥药物是主要治疗方法。然而,副作用和不耐受以及缺乏功效限制了当前抗惊厥药的应用。寻找具有更高功效和更低毒性的新型抗惊厥药仍然是药物化学的重点和任务。大量三唑衍生物作为临床药物或候选药物已广泛用于治疗各种类型的疾病,这已证明该杂环核在药物设计和发现中的重要性。最近,人们进行了许多努力使三唑参与抗惊厥药的设计,这带来了许多活性化合物。这项工作是试图在过去的二十年中系统地回顾三唑衍生物在抗惊厥药的设计和开发中的研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号